Uniphar (LON:UPR) Stock Price Down 1.1% – Here’s Why

Uniphar plc (LON:UPR) dropped 1.1% during trading on Wednesday . The stock traded as low as GBX 178 ($2.25) and last traded at GBX 179 ($2.26). Approximately 6,308 shares were traded during trading, a decline of 82% from the average daily volume of 35,697 shares. The stock had previously closed at GBX 181 ($2.28).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 310 ($3.91) price objective on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Price Performance

The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43. The company has a market capitalization of £483.25 million, a PE ratio of 1,264.29 and a beta of 0.75. The stock’s 50-day moving average is GBX 189.65 and its two-hundred day moving average is GBX 207.77.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.